Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
and plasma cell differentiation. The goal of this project is to test hypotheses about how peripherally circulating B cells can develop into CNS-resident, antibody-secreting cells, to study how
-
and Circularity to strengthen its activities in sustainable photovoltaic technologies. The successful candidate will work at the interface between scientific research, technology development, project
-
. Empa is a research institution of the ETH Domain. The Coating Technologies Group in Empa's Laboratory for Surface Science & Coating Technologies develops next-generation functional thin films through
-
worth living. Empa is a research institution of the ETH Domain. The Coating Technologies Group in Empa's Laboratory for Surface Science & Coating Technologies develops next-generation functional thin
-
-time (100%) postdoc position at the Laboratory for the Chemistry of Materials and Manufacturing (ALCHEMY) at EPFL Neuchatel. At EPFL ALCHEMY, we are focused on developing accessible chemistries and
-
molecular representations, off-target prediction, and experimental feedback. The developed methods will be applied in iterative prospective drug-discovery cycles, with a serine protease from the complement
-
to actively shape the Hub’s development through course delivery and the design and coordination of educational programs. The position includes teaching responsibility for two courses (one per semester
-
Vlasov–Poisson and Vlasov–Maxwell systems). - The position includes teaching responsibilities, such as organising a course and assisting with exam grading. - The anticipated start date is 1st
-
vertically. The project combines urban studies, remote sensing, 3D modelling, environmental science, architecture, political science and participatory approaches to investigate the environmental, social and
-
allergic hypersensitivity, allergy, chronic inflammation and cancer. Besides performing biochemical, cellular and mouse genetic studies, the candidate interacts with Chemists developing novel bioactive small